Can't break out when the CEO won't say anything, or storyline the company and product. We know the potential here, but until document, funding or buyout on Cytocom happens, or revenue documents ate filed, the rest of the investment world thinks this company and Noreen are both a fraud. All we can do is wait and hope Noreen doesn't screw the long and longer investors over. Cross your fingers SPARTANS